Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 2Phase 3 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia, Myeloid, Acute 26Leukemia, Lymphocytic, Chronic, B-Cell 16Myelodysplastic Syndromes 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Lymphoma, Non-Hodgkin 6Lymphoma, Follicular 6Leukemia 6Multiple Myeloma 5Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Recurrence 2Myeloproliferative Disorders 2Lymphoma, Mantle-Cell 2Graft vs Host Disease 2Waldenstrom Macroglobulinemia 1Venentoclax 1Sarcoma, Synovial 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm, Residual 1Melanoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Biphenotypic, Acute 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia 1

Interventions

Ifosfamide 6Doxorubicin 6Radiotherapy 4Filgrastim 2Etoposide 2trofosfamide 1pegfilgrastim 1indolepropanol phosphate 1fludarabine 1anlotinib 1Watchful Waiting 1Tablets 1Rosuvastatin Calcium 1Radiotherapy, Conformal 1Observation 1Midazolam 1Idarubicin 1Digoxin 1Diathermy 1Dacarbazine 1Cyclophosphamide 1Combined Modality Therapy 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Sarcoma, Synovial × fludarabine × Clear all
NCT07174427 2026-02-18

Multi-center Study of TBI-1301 (INN: Mipetresgene Autoleucel; Mip-cel) in Patients With NY-ESO-1 Positive Synovial Sarcoma

Takara Bio Inc.

Phase 3 Recruiting
5 enrolled
Sarcoma

Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡